ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
84 announcements with these filters
Neogen delivered volume-led Q4 growth but faces significant execution hurdles as battery project costs ballooned by ₹250cr+ while timelines shifted to the right.
Neogen Chemicals reported Q4 FY26 consolidated revenue of ₹247 Crore, up 22% Y-o-Y. The Board recommended a ₹1 per share final dividend for the fiscal year.
Neogen Chemicals delivered strong Q4 FY26 results with consolidated revenue growing 22% YoY to ₹247cr. Strategy focuses on high-growth battery materials and agrochem segments.
Neogen Chemicals received an unmodified audit opinion for its FY2026 financial results. This confirmation from auditors validates the company's reported financial integrity for shareholders.
Neogen Chemicals submitted its security cover certificate for Rs. 200 Crore in NCDs. The audit confirms maintenance of required asset coverage for debenture holders.
Neogen Chemicals Ltd reported revenue from operations of ₹246.6 Cr (+21.6% YoY) and net profit of ₹11.4 Cr (+375.0% YoY) for Q4 FY26.
Neogen Chemicals approved FY26 audited results and recommended a Re. 1 per share final dividend. Revenue reached ₹855.49 Crore, demonstrating steady annual growth.
Neogen Chemicals recommended a final dividend of 0.1 per share for FY 2025-26. Shareholders will receive the payout following approval at the general meeting.
Neogen Chemicals will hold a board meeting on May 16, 2026. Directors will consider audited financial results and a final dividend recommendation.
Neogen Chemicals Limited submitted its annual disclosure for the centralized database of non-convertible debentures for FY 2025-26. The filing confirms timely interest payments on its ₹200 Crore NCD issue (ISIN: INE136S07013) listed on BSE. The instrument maintains a 'CRISIL A/Negative' credit rating.
Neogen Chemicals Limited has fixed May 16, 2026, as the record date and May 31, 2026, as the payment date for interest on its secured, listed, non-convertible debentures (ISIN: INE136S07013). This follows SEBI Listing Regulations for debt securities.
Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, created a pledge on 13,19,083 equity shares (5% of paid-up capital) in favour of Axis Trustee Services Limited. The pledge facilitates fund raising by promoter group member Cadamba Solutions Private Limited from Avendus Structured Credit Fund III.
Dr. Harin Haridas Kanani, promoter of Neogen Chemicals Limited, created a pledge on 20,19,167 equity shares (7.65% of paid-up capital) in favour of Axis Trustee Services Limited. The pledge facilitates fundraising for Cadamba Solutions Private Limited, a promoter group member, from Avendus Structured Credit Fund III.
Neogen Chemicals Ltd successfully paid ₹1.56 Crore in interest and principal for its non-convertible debentures on April 28, 2026. This timely payment relates to the ₹200 Crore NCD issue and demonstrates the company's commitment to meeting its debt obligations.
Neogen Chemicals' subsidiary, Neogen Ionics Limited, will subscribe to a ₹100.11 Crore rights issue of its own subsidiary, Neogen Morita New Material Limited. The capital will fund a salt business acquisition, CAPEX, and OPEX requirements. The allotment is expected within 60 days, strengthening the group's position in the lithium-ion battery material space.
Neogen Chemicals Limited allotted 10,00,000 equity shares to promoter-group entity Cadamba Solutions Private Limited on a preferential basis for ₹161 Crore. The allotment constitutes 3.65% of the post-issue paid-up capital, strengthening the company's equity base.
Neogen Chemicals Ltd allotted 10,00,000 equity shares to promoter group member Cadamba Solutions Private Limited on a preferential basis. The transaction, valued at ₹161 Crore, was executed at ₹1,610 per share. This infusion increases the promoter group's stake and strengthens the company's capital base.
Neogen Chemicals Limited allotted 10,00,000 equity shares to promoter group member Cadamba Solutions Private Limited via a Rs. 161 Crore preferential issue. The shares were issued at Rs. 1,610 each, representing 3.65% of the post-allotment paid-up capital. This capital infusion strengthens the company's financial position for future growth.
Neogen Chemicals Limited has allotted 10,00,000 equity shares on a preferential basis to promoter group member Cadamba Solutions Private Limited. The allotment was priced at ₹1,610 per share, representing a total fundraise of ₹161.0 Crore. This capital infusion strengthens the company's financial position and increases its paid-up share capital.
Neogen Chemicals Limited allotted 10,00,000 equity shares to Cadamba Solutions Private Limited on a preferential basis, raising ₹161 Crore. The issue price was ₹1,610 per share, including a ₹1,600 premium. This allotment increases the company's paid-up equity capital to ₹27.38 Crore and the shares are subject to an 18-month lock-in period.
Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, pledged 20,19,167 equity shares (7.65% stake) on April 13, 2026. The pledge was created in favour of Axis Trustee Services Limited to facilitate fund raising for Cadamba Solutions Private Limited, a promoter group member.
Axis Trustee Services Limited, acting as a Debenture Trustee, has received a pledge of 20,19,167 equity shares (7.65% stake) in Neogen Chemicals Limited. The transaction was executed on April 13, 2026, in its capacity as a pledgee. The trustee clarifies it holds no beneficial interest in the shares.
Neogen Chemicals Ltd submitted its half-yearly statement for NCDs totaling ₹200 Crore. The debentures, issued on August 12, 2025, carry a 10.50% monthly coupon and mature in February 2028. Both the issuer and holders have call/put options exercisable starting August 12, 2027.
Neogen Chemicals Ltd has fixed April 15, 2026, as the record date for the payment of interest on its listed Non-Convertible Debentures (ISIN: INE136S07013). The interest payment is scheduled to be made on April 30, 2026, in compliance with SEBI listing regulations.